AV¶ÌÊÓƵ

Muriel Cuendet earned her degree in pharmacy from the AV¶ÌÊÓƵ of Lausanne in 1994, followed by a PhD in Pharmaceutical Sciences from the same university in 1999. She then completed a postdoctoral fellowship at the AV¶ÌÊÓƵ of Illinois at Chicago (USA) from 1999 to 2003. Between 2003 and 2009, she held two academic positions in the US: Research Assistant Professor (2003–2005, AV¶ÌÊÓƵ of Illinois at Chicago) and Visiting Assistant Professor (2005–2006, Purdue AV¶ÌÊÓƵ). She also worked as a Research Scientist at the Murphy Cancer Foundation (West Lafayette, IN, 2007–2009). In 2009, Muriel Cuendet returned to Switzerland as Associate Professor in the Section of Pharmaceutical Sciences at the AV¶ÌÊÓƵ, and was promoted to Full Professor in 2024.

Muriel Cuendet’s research focuses on the anticancer activity of natural and synthetic products, with two main areas: (i) identifying plant extracts and natural compounds capable of inhibiting one or more stages of carcinogenesis; and (ii) characterizing the mechanisms of action of these compounds by studying the signaling pathways affected in various cancers such as multiple myeloma and lung cancer.